Ichnos Sciences

Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field
Biopharma Dive
Tue, 10/15/19 - 10:21 pm
Glenmark
Ichnos Sciences
India
Amgen
oncology
Regeneron
bispecific antibodies